About Candida Fratazzi, M.D. has 25 years’ experience in biomedical research.
Dr Fratazzi devised the concept of a Strategic Clinical Innovation Organization (SCIO) and founded the first SCIO –Boston Biotech Clinical Research (BBCR), LLC in 2009, with the objective of actively contributing to innovation in clinical research.
As the President of BBCR, LLC, Dr. Fratazzi acts as a consultant to biotech, pharmaceutical and medical device companies of all sizes:
• She advises her clients on optimum clinical plan development and how to design clinical trials that reduce the risk of late-stage failure.
• In addition, Dr. Fratazzi is:
o A member of the Scientific Advisory Board at Hassuji T...